Investing.com – Pharmaceutical stocks were boosted Wednesday by Donald Trump’s surprise presidential win.
During his campaign, Trump said he would dismantle Obama’s healthcare program.
Sector was sold prior to election result as Clinton was seen increasing controls on drug pricing.
In the U.S., Pfizer (NYSE:PFE) was up over 4% in pre-market trade as Mylan (NASDAQ:MYL) added over 6%.
European pharmaceuticals stocks were also higher.